Matches in Wikidata for { <http://www.wikidata.org/entity/Q95056301> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q95056301 description "clinical trial" @default.
- Q95056301 description "ensayo clínico" @default.
- Q95056301 description "ensayu clínicu" @default.
- Q95056301 description "klinisch onderzoek" @default.
- Q95056301 description "клінічне випробування" @default.
- Q95056301 description "临床试验" @default.
- Q95056301 name "Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study" @default.
- Q95056301 name "Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study" @default.
- Q95056301 type Item @default.
- Q95056301 label "Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study" @default.
- Q95056301 label "Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study" @default.
- Q95056301 prefLabel "Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study" @default.
- Q95056301 prefLabel "Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study" @default.
- Q95056301 P1132 Q95056301-1C7E4383-CED4-4E0C-9323-8C32A94DA73A @default.
- Q95056301 P1476 Q95056301-6D2F40C9-D215-47B0-9B78-EB96CB4147A8 @default.
- Q95056301 P17 Q95056301-3637784E-AC77-4E1E-9685-517815798F3B @default.
- Q95056301 P2899 Q95056301-1F01DAFF-FFF6-4E34-882F-96FAFB293D33 @default.
- Q95056301 P3098 Q95056301-71D5A1C3-EB9F-47EF-8911-F8C9A396690B @default.
- Q95056301 P31 Q95056301-61BC3567-8B58-4877-819C-D4B828525A9E @default.
- Q95056301 P4844 Q95056301-13AE9DFD-3DBE-415E-952C-DF6C574D7C60 @default.
- Q95056301 P580 Q95056301-3D3931CE-5A21-4FE2-9E6B-043D9AD1BF2B @default.
- Q95056301 P582 Q95056301-0CF12FBC-361A-457B-B20E-94C1BEE2E34A @default.
- Q95056301 P6099 Q95056301-33028201-FBBD-450D-92E1-3E30475CBCAC @default.
- Q95056301 P767 Q95056301-628468D7-C97E-4CB8-8ECD-E624D975886B @default.
- Q95056301 P8005 Q95056301-3B5058F0-8D81-447E-A7F6-CADBB61CE91A @default.
- Q95056301 P8363 Q95056301-CED72DAC-011F-4535-9869-060FE9187F1C @default.
- Q95056301 P859 Q95056301-0C706262-9927-4FFD-9824-5F9DB23ECA07 @default.
- Q95056301 P1132 "+90" @default.
- Q95056301 P1476 "GEMINI: An Open-Label, Single-Arm, Phase II Study of Intraoperative Gemcitabine Intravesical Instillation in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma" @default.
- Q95056301 P17 Q30 @default.
- Q95056301 P2899 "+18" @default.
- Q95056301 P3098 "NCT04398368" @default.
- Q95056301 P31 Q30612 @default.
- Q95056301 P4844 Q414143 @default.
- Q95056301 P580 "2020-05-31T00:00:00Z" @default.
- Q95056301 P582 "2024-05-15T00:00:00Z" @default.
- Q95056301 P6099 Q42824440 @default.
- Q95056301 P767 Q664846 @default.
- Q95056301 P8005 Q76649614 @default.
- Q95056301 P8363 Q78089383 @default.
- Q95056301 P859 Q1130172 @default.